HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 604 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,391,385 | +17.8% | 46,602 | +4.7% | 0.11% | +11.0% |
| Q2 2023 | $4,576,825 | +0.7% | 44,500 | +6.8% | 0.10% | -9.1% |
| Q1 2023 | $4,546,663 | +2.0% | 41,659 | +6.3% | 0.11% | -12.0% |
| Q4 2022 | $4,457,887 | +113.0% | 39,173 | +15.8% | 0.12% | +98.4% |
| Q3 2022 | $2,093,000 | +17.3% | 33,819 | +51.2% | 0.06% | +10.5% |
| Q2 2022 | $1,784,000 | -22.2% | 22,365 | +2.6% | 0.06% | -19.7% |
| Q1 2022 | $2,293,000 | +163.6% | 21,790 | +169.8% | 0.07% | +153.6% |
| Q4 2021 | $870,000 | +15.8% | 8,076 | +17.8% | 0.03% | -6.7% |
| Q3 2021 | $751,000 | +6.8% | 6,855 | -8.7% | 0.03% | 0.0% |
| Q2 2021 | $703,000 | -84.4% | 7,508 | -84.6% | 0.03% | -85.0% |
| Q1 2021 | $4,495,000 | +203.1% | 48,833 | +140.8% | 0.20% | +308.2% |
| Q4 2020 | $1,483,000 | -22.0% | 20,279 | -71.0% | 0.05% | +44.1% |
| Q3 2019 | $1,902,000 | – | 69,852 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paulson & Co. | 6,100,000 | $377,529,000 | 27.63% |
| Kopp Family Office, LLC | 542,543 | $33,578,000 | 27.33% |
| Prosight Management, LP | 303,000 | $18,753,000 | 10.05% |
| Eversept Partners, LP | 1,269,591 | $78,574,987 | 6.81% |
| Octagon Capital Advisors LP | 624,500 | $38,650,000 | 6.67% |
| Avoro Capital Advisors LLC | 5,125,000 | $317,186,000 | 5.86% |
| 1492 Capital Management LLC | 119,836 | $7,417,000 | 5.34% |
| Velan Capital Investment Management LP | 68,829 | $4,260,000 | 4.22% |
| Deep Track Capital, LP | 1,462,800 | $90,533,000 | 4.15% |
| Ally Bridge Group (NY) LLC | 74,262 | $4,596,000 | 3.03% |